Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)?

You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)? You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Acute Myeloid Leukemia (AML) Clinical Trial
NCT02013648 | Phase 3 | Interventional
University of Ulm
Sponsored by
University of Ulm

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)?

You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)? You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Active not recruiting

Male & Female

18 Years +

This study is looking to recruit 203 Participants

This is a randomized phase III open-label, multicenter trial evaluating standard induction therapy (daunorubicin [DNR] and cytarabine [Ara-C]) and consolidation therapy (high-dose cytarabine [HDAC]) with or without dasatinib in adult patients with newly diagnosed CBF-AML